DuPont de Nemours (DD) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

DuPont de Nemours

NYSE•Basic Materials•Specialty Chemicals

$128.46+0.89(0.01%)After hours

Market Cap

$17.55B

P/E

319.0x

P/S

4.4x

P/B

1.3x

DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through two segments, Healthcare & Water Technologies and Diversified Industrials. The company offers specialty components for medical devices, packaging and garments, and protective suits under the brand TYVEK; provides water filtration and separation solutions, including elements, modules, and systems serving primarily industrial wastewater and energy markets, municipal and desalination applications, and life sciences and specialty sectors. It also offers AMBERLITE ion exchange resins, FILMTEC reverse osmosis and nanofiltration elements, and INGE and ITEGRATEC ultrafiltration modules. In addition, the company offers engineered products and integrated solutions for the non-residential, residential, and repair-and-remodel construction markets, includes TYVEK house wrap, STYROFOAM insulation, and CORIAN solid surface. Further, it engages in the design and production of engineered components, systems, and process solutions used in OEM and operational applications, such as automotive, aerospace, printing, and packaging. Additionally, the company offers Vespel shapes and parts, MOLYKOTE specialty lubricants, BETAFORCE and BETASEAL structural adhesives, and Cyrel flexographic printing plates. The company was formerly known as DowDuPont Inc. and changed its name to DuPont de Nemours, Inc. in June 2019. DuPont de Nemours, Inc. was incorporated in 2015 and is headquartered in Wilmington, Delaware.

How this company scores

GoodMetricSide Score: 63/100

Strongest: Profitability (19/25); weakest: Growth (12/25).

Profitability19/25

Growth12/25

Balance Sheet & Red Flags17/25

Cash & Earnings Quality15/25

Strengths

Strong marginsRising earningsLow leverageCash-backed earnings

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 319.0x5y range 2.3x – 319.0x

Currently above its 15-quarter median.

P/S · 4.4x5y range 0.7x – 4.4x

Currently above its 20-quarter median.

P/B · 1.3x5y range 0.4x – 1.3x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

The company posted negative operating margins in recent quarters — core operations are unprofitable.

Earnings Quality

Watch

FCF/Net Income has dropped below 0.7x in 3 quarters — monitor for earnings quality deterioration.

Price & Volume

Market Cap $17.55B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $4.03B
Q. Revenue: $1.82B
TTM EBITDA: $1.13B
TTM Op. Income: $766.00M
Q. Op. Income: $224.00M
TTM Net Income: $55.00M
Q. Net Income: $143.00M
EPS: $1.05
Shares Out.: $135.90M

$4.03B in TTM revenue declined 68.1% YoY, reaching $1.82B last quarter. TTM EBITDA of $1.13B and TTM operating income of $766.00M show growth is flowing through to the bottom line. TTM net income of $55.00M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has fallen for 4 consecutive quarters — a weakening trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 35.1%
EBITDA Margin: 20.8%
Op. Margin: 12.3%
Net Margin: 7.9%

Op. margin of 12.3% is up 2.5% YoY — cost efficiency is improving. Net margin at 7.9% and gross margin of 35.1% show how much of each revenue dollar survives to profit. Across the last 8 quarters, operating margin has risen for 2 consecutive quarters — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 319.0x
P/S Ratio: 4.4x
P/B Ratio: 1.3x

At 319.0x P/E, the stock trades above typical market levels — the market expects above-average growth. P/S of 4.4x and P/B of 1.3x provide additional context. P/E sits above typical market levels while revenue growth is below 5%. Over the past year, P/E is up 0% — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $21.06B
Cash: $1.74B
Long-Term Debt: $3.13B
Book Value: $13.77B
D/E Ratio: 0.2
Debt/EBITDA: 8.3

With $21.06B in assets and $3.13B in long-term debt, D/E is 0.2and book value is $13.77B — a conservative capital structure with a cushion to weather downturns. Over the past year, debt/equity is down 2% — a weakening trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $400.00M
TTM Free Cash Flow: $283.00M
FCF Margin: 7.0%
FCF / Net Income: 5.1

TTM FCF of $283.00M on $400.00M in operating cash flow. The FCF / Net Income ratio of 5.1x means free cash flow covers net income — earnings are backed by cash. Over the past year, free cash flow is down 80% — an improving trend.